IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TRIPODI, ARMANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.751
AS - Asia 15.837
NA - Nord America 15.709
SA - Sud America 1.830
AF - Africa 313
OC - Oceania 103
Continente sconosciuto - Info sul continente non disponibili 21
Totale 54.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.217
GB - Regno Unito 6.820
SG - Singapore 4.910
CN - Cina 4.503
IT - Italia 3.561
DE - Germania 2.403
RU - Federazione Russa 2.027
SE - Svezia 1.621
HK - Hong Kong 1.402
BR - Brasile 1.258
TR - Turchia 1.093
VN - Vietnam 1.009
FR - Francia 936
KR - Corea 789
IE - Irlanda 713
UA - Ucraina 687
NL - Olanda 660
IN - India 610
BD - Bangladesh 559
FI - Finlandia 511
EU - Europa 372
CA - Canada 263
JP - Giappone 199
CO - Colombia 198
ID - Indonesia 188
AR - Argentina 157
ES - Italia 157
MX - Messico 137
PL - Polonia 94
AU - Australia 86
IQ - Iraq 78
CI - Costa d'Avorio 76
GR - Grecia 66
TW - Taiwan 62
DK - Danimarca 59
RO - Romania 59
AT - Austria 57
CL - Cile 51
PK - Pakistan 51
BE - Belgio 50
PE - Perù 48
PH - Filippine 46
TH - Thailandia 45
EC - Ecuador 44
EG - Egitto 43
ZA - Sudafrica 42
CH - Svizzera 37
PT - Portogallo 31
UZ - Uzbekistan 30
VE - Venezuela 28
AE - Emirati Arabi Uniti 26
LU - Lussemburgo 26
MY - Malesia 26
SA - Arabia Saudita 26
IL - Israele 25
NO - Norvegia 24
TN - Tunisia 24
NG - Nigeria 23
MA - Marocco 22
PY - Paraguay 21
HU - Ungheria 20
KH - Cambogia 20
CR - Costa Rica 19
DZ - Algeria 18
UY - Uruguay 17
KE - Kenya 16
AZ - Azerbaigian 15
JO - Giordania 15
NP - Nepal 15
CZ - Repubblica Ceca 14
HR - Croazia 14
IR - Iran 14
NZ - Nuova Zelanda 14
RS - Serbia 14
JM - Giamaica 13
KZ - Kazakistan 12
BY - Bielorussia 11
EE - Estonia 11
LT - Lituania 10
BG - Bulgaria 9
DO - Repubblica Dominicana 9
SN - Senegal 9
OM - Oman 8
PS - Palestinian Territory 8
SK - Slovacchia (Repubblica Slovacca) 8
BO - Bolivia 7
ET - Etiopia 7
GT - Guatemala 7
MD - Moldavia 7
MK - Macedonia 7
HN - Honduras 6
LB - Libano 6
PA - Panama 6
SI - Slovenia 6
TT - Trinidad e Tobago 6
YE - Yemen 6
AL - Albania 5
BW - Botswana 5
GE - Georgia 5
KW - Kuwait 5
Totale 54.810
Salva come PNG Salva come JPEG
Città #
Southend 6.369
Singapore 2.724
Hong Kong 1.289
Hanover 1.216
Seattle 1.190
Ashburn 1.075
Chandler 1.053
San Jose 1.031
Princeton 847
Beijing 838
Milan 834
Dublin 696
Wilmington 660
Council Bluffs 622
Dallas 489
Redmond 471
Jacksonville 384
Lauterbourg 369
Los Angeles 360
Mountain View 352
Nanjing 341
Bengaluru 331
Des Moines 320
Sakarya 317
Guangzhou 301
Moscow 292
Ho Chi Minh City 268
Santa Clara 264
Fairfield 244
New York 244
Buffalo 239
Boardman 231
Hanoi 228
Frankfurt am Main 225
Houston 222
Hefei 211
Shanghai 211
Woodbridge 205
Dearborn 197
Ann Arbor 195
Redwood City 181
Serra 175
Andover 164
Columbus 163
Rome 149
Bogotá 147
The Dalles 138
São Paulo 130
Somerville 119
Helsinki 117
Tianjin 114
Toronto 109
Seoul 105
Shenyang 101
Tokyo 100
Shenzhen 99
Cangzhou 96
Hangzhou 88
Cambridge 86
Dong Ket 85
Jinan 84
Hebei 80
Nanchang 80
Abidjan 76
Eitensheim 76
Chicago 69
Bitonto 66
Jakarta 66
Roxbury 66
Pisa 63
Changsha 61
Zhengzhou 53
Istanbul 52
Phoenix 50
Bologna 48
Warsaw 47
Berlin 46
Jiaxing 46
Haiphong 43
Meppel 43
Naples 43
Turin 43
Mumbai 41
Munich 41
Taipei 41
Medford 40
Nuremberg 39
Belo Horizonte 38
Fuzhou 36
Paris 36
Brussels 35
Falls Church 35
Montreal 35
Rio de Janeiro 35
Saint Petersburg 34
San Diego 34
Athens 33
Kunming 33
Buenos Aires 32
Baghdad 31
Totale 32.371
Salva come PNG Salva come JPEG
Nome #
Hemostasis in acute and chronic liver disease 1.458
Liver Disease and Hemostatic (Dys)function 952
PM exposure increases coagulation function : a study among highly exposed steel workers in Italy 637
Is placental blood a reliable source for the evaluation of neonatal hemostasis at birth? 608
International survey on D-dimer test reporting: a call for standardization 562
Procoagulant imbalance in Klinefelter syndrome assessed by thrombin generation assay and whole blood thromboelastometry 522
Relationship between thrombin generation parameters and prothrombin fragment 1 + 2 plasma levels 412
Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants 403
World Health Organization (WHO) Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy 344
Thrombin Generation in Preterm Newborns With Intestinal Failure-Associated Liver Disease 344
Hypercoagulability in splenectomized thalassemic patients detected by whole-blood thromboelastometry, but not by thrombin generation in platelet-poor plasma 336
Carenza di pre-callicreina e tempo di tromboplastina parziale attivato (APTT) 329
Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia 301
Different cut-off values of quantitative D-dimer methods to predict the risk of venous thromboembolism recurrence : a post-hoc analysis of the PROLONG study 285
Esposizione a polveri sottili in acciaieria : effetti su infiammazione, coagulazione, markers epigenetici 271
Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban 268
Guidelines for thromboplastins and plasma used to control oral anticoagulant therapy with vitamin K antagonists 253
Responsiveness of the activated partial thromboplastin time and dilute thrombin time to argatroban: Results of an in vitro study 251
Rational hemostatic management in cirrhosis: from old paradigms to new clinical challenges 248
Effects of PM Exposure on coagulation indexes among steel workers in Italy 248
Hemostatic alterations in COVID-19 247
Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis 244
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study 240
Body mass index reduction improves the baseline procoagulant imbalance of obese subjects 237
Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method 233
Use of D-dimer testing to determine duration of anticoagulation, risk of cardiovascular events and occult cancer after a first episode of idiopathic venous thromboembolism : the extended follow-up of the PROLONG study 232
An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis 231
Le variabili preanalitiche nello studio dell'emostasi 230
Unbalanced oxidative status in idiopathic sudden sensorineural hearing loss 224
Hypercoagulability in Patients with Type 2 Diabetes Mellitus Detected by a Thrombin Generation Assay 222
The D-dimer (DD) test to establish the duration of anticoagulation after a first unprovoked episod of venous thromboembolism (VTE); the prospective randomized “Prolong” Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA) 218
An improved method for measuring red blood cell filterability 216
Congenital deficiencies of anticoagulant proteins (Antithrombin III and Protein C) 213
Procoagulant imbalance in patients with non-alcoholic fatty liver disease 212
International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain 207
Rescue FVIII replacement to secure haemostasis in a patient with haemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement 207
Normal thrombin generation in neonates in spite of prolonged conventional coagulation tests 205
The validity of the INR system for patients with liver disease 205
Blood hypomethylation of inflammatory genes mediates the effects of metal-rich airborne pollutants on blood coagulation 203
Testosterone therapy does not affect coagulation in male hypogonadism: a longitudinal study based on thrombin generation 203
Increased thrombin generation in inflammatory bowel disease 201
Effects of inhalable particulate matter on blood coagulation 201
A comparison of linear and orthogonal regression analysis for local INR determination in ECAA coagulometer studies 199
Risk of relapse after SARS-CoV-2 vaccine in the Milan cohort of thrombotic thrombocytopenic purpura patients 195
Effect of PM Exposure on Coagulation among Steel Workers in Italy 195
The Italian START-Register on anticoagulation with focus on atrial fibrillation 194
The coagulopathy of cirrhosis assessed by thromboelastography and its correlation with conventional coagulation parameters 192
Advances in the treatment of hemophilia: Implications for laboratory testing 192
A partial factor V deficiency in anticoagulated lyophil¬ized plasmas was identified as a cause of the International Normalized Ratio discrepancy in External Quality Assessment Scheme 190
Harmful and Beneficial Effects of Anti-coagulants in Patients With Cirrhosis and Portal Vein Thrombosis 188
Thrombin generation in patients with cirrhosis : the role of platelets 187
Thrombin generation in plasma from patients with cirrhosis supplemented with normal plasma : considerations on the efficacy of treatment with fresh-frozen plasma 181
European Concerted Action on Anticoagulation : a multicentre calibration study of WHO international reference preparations for thromboplastin, rabbit (RBT/90) and human (rTF/95) 179
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests 173
Performance of clinical laboratories for DNA analyses to detect thrombophilia mutations 173
Resistance to thrombomodulin is associated with de novo portal vein thrombosis and low survival in patients with cirrhosis 173
The detection of lupus anticoagulants in hemophiliacs : the need for different assay systems 172
Anti-TNF-α treatment reduces the baseline procoagulant imbalance of patients with inflammatory bowel diseases 172
The natural history of D-dimer after anticoagulation suspension for a first episode of idiopathic venous thromboembolism : the prolong II study 171
Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis 171
Whole blood platelet aggregation measurement by Multiplate™: potential diagnostic inaccuracy of correcting the results for the sample platelet count 169
Study of the thrombin generation in patients with liver cirrhosis 169
Procoagulant imbalance in preterm neonates detected by thrombin generation procedures 169
Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction 168
Hyperprothrombinaemia-induced APC resistance : differential influence on fibrin formation and fibrinolysis 167
Laboratory monitoring of anticoagulation : where do we stand? 166
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism 166
Hypercoagulability in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD): Causes and Consequences 166
The history of phenotypic testing in thrombosis and hemostasis 165
Hypercoagulability in patients with Cushing disease detected by thrombin generation assay is associated with increased levels of neutrophil extracellular trap-related factors 165
Point-of-care coagulation monitors calibrated for the international normalized ratio for cirrhosis (INRliver) can help to implement the INRliver for the calculation of the MELD score 164
A guide to oral anticoagulant treatment. Recommendations of the Italian federation of anticoagulation clinics (FCSA) 164
Relatively poor performance of clinical laboratories for DNA analyses in the detection of two thrombophilic mutations : a cause for concern 163
Thrombin generation assay for testing hemostatic effect of factor VIII concentrates in patients with hemophilia A and inhibitors: In vitro results from the PredicTGA study 163
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII : considerations on the differentiation between the 2 circulating anticoagulants 162
Simvastatin Prevents Liver Microthrombosis and Sepsis Induced Coagulopathy in a Rat Model of Endotoxemia 162
Severe hemophilia with mild bleeding phenotype : molecular characterization and global coagulation profile 161
A multicentre calibration study of WHO International Reference Preparations for thromboplastin, rabbit (RBT/90) and human (rTF/95) 160
Homozygous protein C deficiency with moderately severe clinical symptoms 160
Italian experience in the assessment of performance of clinical laboratories for DNA analyses to detect three thrombophilic mutations 158
The role of erytrocyte deformability in the prolonged bleeding time in liver disease patients 158
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage 156
Dosaggio dell'alfa-2 antiplasmina 156
Comparative Investigation of Thromboelastometry and Thrombin Generation for Patients Receiving Direct Oral Anticoagulants or Vitamin K Antagonists 155
Biological variation of INR in stable patients on long-term anticoagulation with warfarin 155
The coagulopathy of cirrhosis assessed by thromboelastometry and its correlation with conventional coagulation parameters 154
The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation 153
Assessment of a new instrument (Coag-A-Mate X2) for performing global clotting tests and specific factor assays 153
A review of the clinical and diagnostic utility of laboratory tests for the detection of congenital thrombophilia 152
Hemostatic balance in patients with liver cirrhosis : report of a consensus conference 152
Abnormalities of hemostasis and bleeding in chronic liver disease : the paradigm is challenged 150
A comparison of artificially-depleted, lyophilized coumarin and fresh coumarin plasmas in thromboplastin calibration 149
Dosaggio del plasminogeno 149
D-dimer testing to determine the duration of anticoagulation therapy 148
Multicenter study of Homocysteine measurement. Performance characteristics of different methods, influence of standards on interlaboratory agreement of results 147
Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents 147
Thromboelastographic profiles of healthy very low birthweight infants serially during their first month 147
Performance of Quantitative D-Dimer Methods. Results of the Italian External Quality Assessment Scheme 146
Abnormalities of Hemostasis in Chronic Liver Disease: Reappraisal of their Clinical Significance and Need for Clinical and Laboratory Research 146
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13) 146
Totale 23.466
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.975
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.975
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021316 0 0 0 0 0 0 0 0 0 0 0 316
2021/20224.475 245 134 145 367 454 239 354 339 456 534 479 729
2022/20234.729 626 284 318 633 578 1.055 136 309 440 83 194 73
2023/20242.404 98 239 124 142 493 80 67 125 37 143 391 465
2024/20256.550 327 744 154 509 465 254 254 950 504 463 648 1.278
2025/202615.279 1.093 740 1.847 1.379 1.546 1.164 1.748 1.161 1.883 1.079 1.363 276
Totale 57.575